E. Morel

发表

Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence

G. Perrault, D. Sanger, B. Zivkovic, 1993, Neuropharmacology.

Animal models of anxiety and the development of novel anxiolytic drugs

G. Perrault, D. Sanger, B. Zivkovic, 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Animal Models and Recent Developments in the Search for Novel Anxiolytics

G. Perrault, D. Sanger, B. Zivkovic, 1991 .

Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.

G. Perrault, D. Sanger, B. Zivkovic, 1990, European journal of pharmacology.

The interaction between zolpidem and beta-CMC: a clue to the identification of receptor sites involved in the sedative effect of zolpidem.

G. Perrault, D. Sanger, B. Zivkovic, 1988, European journal of pharmacology.

Possible role of hydroxymetabolites in the action of neuroleptics

S. Dahl, K. Lloyd, E. Morel, 1983 .

Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes

G. Perrault, D. Sanger, C. Cohen, 1994, Neuroscience & Biobehavioral Reviews.

Pharmacological and Behavioral Profile of Alpidem as an Anxiolytic

G. Perrault, D. Sanger, K. Lloyd, 1990, Pharmacopsychiatry.

The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure

D. J. Sanger, E. Morel, G. Perrault, 1987, Physiology & Behavior.

Anti-apomorphine effects of phenothiazine drug metabolites

E. Morel, S. Dahl, K. Lloyd, 2004, Psychopharmacology.

Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem.

G. Perrault, D. Sanger, E. Morel, 1996, European journal of pharmacology.

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.

D J Sanger, R. Depoortère, G. Perrault, 1997, The Journal of pharmacology and experimental therapeutics.

Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.

G. Perrault, D. Sanger, E. Morel, 1992, The Journal of pharmacology and experimental therapeutics.

In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.

G. Perrault, B. Scatton, A. Dubois, 1988, The Journal of pharmacology and experimental therapeutics.

Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice

G. Perrault, D. Sanger, E. Morel, 1992, Pharmacology Biochemistry and Behavior.

[Role of central catecholamines in the psychostimulant activity of pyrovalerone].

E. Morel, C. Demarty, J. Rapin, 1976, Archives internationales de pharmacodynamie et de therapie.